FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/05/052761 [Registered on: 17/05/2023] Trial Registered Prospectively
Last Modified On: 23/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda
Other (Specify) 
Study Design  Single Arm Study 
Public Title of Study   Role of Guda Haritaki in Gout 
Scientific Title of Study   Efficacy of Guda Haritaki in the disintegration of pathogenesis of Vatarakta (Gout)- A single arm clinical trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Preeti 
Designation  PG Scholar 
Affiliation  Chaudhary brahm prakash ayurved charak sansthan khera dabar Najafgarh New Delhi 110073 
Address  PG Department of Rog Nidan Evum Vikruti Vigyan, Chaudhary Brahm Prakash Ayurved Charak Sansthan, Khera Dabar, Najafgarh New Delhi 110073

South West
DELHI
110073
India 
Phone  9315412844  
Fax    
Email  preetiranta4@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Aditaya Nath Tewari 
Designation  Associate Professor 
Affiliation  Chaudhary Brahm Prakash Ayurved Charak Sansthan, Khera Dabar Najafgarh NEW Delhi 110073 
Address  PG Department of Rog Nidan Evum Vikruti Vigyan, Chaudhary Brahm Prakash Ayurved Charak Sansthan, Khera Dabar Najafgarh New Delhi 110073

West
DELHI
110073
India 
Phone    
Fax    
Email  dr.aditaya@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Aditaya Nath Tewari 
Designation  Associate Professor 
Affiliation  Chaudhary Brahm Prakash Ayurved Charak Sansthan, Khera Dabar Najafgarh New Delhi 110073 
Address  PG Department of Rog Nidan Evum Vikruti Vigyan, Chaudhary Brahm Prakash Ayurved Charak Sansthan, Khera Dabar, Najafgarh New Delhi 110073

South West
DELHI
110073
India 
Phone    
Fax    
Email  dr.aditaya@gmail.com  
 
Source of Monetary or Material Support  
Chaudhary Brahm Prakash Ayurved Charak Sansthan 
 
Primary Sponsor  
Name  Ch. Brahm Prakash Ayurved Charak Sansthan 
Address  Chaudhary Brahm Prakash Ayurved Charak Sansthan, Khera Dabar, New Delhi, 110073 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Preeti  Ch. Brahm Prakash Ayurved Charak Sansthan  Chaudhary Brahm Prakash Ayurved Charak Sansthan, Khera Dabar
South West
DELHI 
9315412844

preetiranta4@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC - CBPACS  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M109||Gout, unspecified. Ayurveda Condition: VATARAKTAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Guda Haritaki, Reference: Chakradutta, Vatarakta Chikitsa : chapter 23, 8, Route: Oral, Dosage Form: Churna/ Powder, Dose: 6(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: -Guduchi kashaya), Additional Information: -
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Clinically diagnosed patients of Vatarakta (Gout) with Hyperuricaemia and presenting with the classical sign and symptoms of Vatarakta (Gout)
Subjects consenting to participate in the study 
 
ExclusionCriteria 
Details  Subjects suffering from other systemic illnesses
Subjects suffering from autoimmune diseases of the joints
Pregnant and lactating women
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
This study is expected to be helpful in the management of Vatarakta (Gout)
 
45 days
 
 
Secondary Outcome  
Outcome  TimePoints 
This study will provide cost effective, safe drug with lesser side effects  12 months 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "45"
Final Enrollment numbers achieved (India)="45" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   01/06/2023 
Date of Study Completion (India) 15/05/2024 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) 15/05/2024 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Completed 
Recruitment Status of Trial (India)  Completed 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Vatarakta is Vata pradhan Tridoshaj Vyadhi and its main Dushya is Rakta. According to Acharya Sushrut "Akhorvishamiv  krudham deham anusarpati" (in aggravated stage, it spreads in whole body like rat poison)

Gout is typically characterized by episodic acute and chronic arthritis and pain and swelling of first metatarsophalangeal joint initially, followed by involvement of other joints.

Hyperuricaemia leads to formation and deposition of monosodium urate crystals (MSU crystals) which advantageously deposits in bursa, joints, tendons and its spaces and eventually forms nodular swellings called tophi.

Vatarakta (Gout) is a common presentation with symptoms like severe pain, inflammation, burning sensation and tenderness in the affected joints.
Small joints of feet and hands are mainly affected in Gout.

Present study is aimed to evaluate the efficacy of Guda Haritaki with Guduchi Kashaya in Vatarakta (Gout)

Study type is interventional and study design is Single Arm Clinical Trial with sample size of 50 patients.
3gm of Haritaki along with 3gm of Guda will be given with 40 ml of Guduchi Kashaya, twice daily, before meals for 45 days.
This study is expected to be helpful in clinical management of Vatarakta (Gout)

 
Close